{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:02:29Z","timestamp":1790226149458,"version":"4.1.0"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Epidemiological research has indicated a potential association between the triglyceride-glucose (TyG) index and the risk of major adverse cardiocerebrovascular events (MACCE). Nevertheless, the precise nature and magnitude of this relationship remain to be fully elucidated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aims to assess the dose\u2013response relationship between the TyG index and MACCE among individuals with cardiovascular-kidney-metabolic (CKM) syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A comprehensive literature search was conducted using the PubMed and Web of Science databases to identify relevant studies on the TyG-MACCE relationship up to 16 June 2026. Data were synthesized using both random- and fixed-effects models, and nonlinear dose\u2013response meta-analyses were performed using restricted cubic spline models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The analysis incorporated eight cohort studies, encompassing over two million participants and 179 thousand MACCE cases. The aggregated risk estimate for MACCE, comparing the highest to the lowest categories of TyG index exposure, was 1.20 (95% confidence interval [CI]\n                      <jats:italic>=<\/jats:italic>\n                      1.11\u20131.30,\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u00a0=\u00a077.2%,\n                      <jats:italic>p<\/jats:italic>\n                      <jats:sub>heterogeneity<\/jats:sub>\n                      &amp;lt; 0.001). The dose\u2013response analysis revealed a nonlinear positive association between the TyG index and MACCE risk (\n                      <jats:italic>p<\/jats:italic>\n                      <jats:sub>nonlinear<\/jats:sub>\n                      &amp;lt; 0.001), with summary risk estimates calculated for each 1-unit increment in the TyG index being 1.05 (95% CI\n                      <jats:italic>=<\/jats:italic>\n                      1.02\u20131.08,\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u00a0=\u00a081.1%,\n                      <jats:italic>p<\/jats:italic>\n                      <jats:sub>heterogeneity<\/jats:sub>\n                      &amp;lt; 0.001). Subgroup and sensitivity analyses yielded similar results.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This suggests that the TyG index may contribute to adverse MACCE in individuals with CKM syndrome. Further studies are needed to confirm causality and the predictive power of the TyG index.<\/jats:p>\n                    <jats:p>The research was prospectively registered in the Prospective Register for Systematic Reviews (registration number: CRD420261278535).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420261278535<\/jats:ext-link>\n                      , identifier CRD420261278535.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1959631","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:37:00Z","timestamp":1790224620000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Linking the triglyceride-glucose index to major adverse cardiocerebrovascular events in individuals with cardiovascular-kidney-metabolic syndrome: insights from an aggregate-data systematic review and dose\u2013response meta-analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Leilei","family":"Liu","sequence":"first","affiliation":[{"name":"Clinical Trials Center & Key Laboratory of Clinical Pharmacology and Translational Research, The Affiliated Hospital of Guizhou Medical University","place":["Guiyang, China"]},{"name":"School of Public Health, the Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Public Health, the Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Public Health, the Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqin","family":"Zhong","sequence":"additional","affiliation":[{"name":"School of Public Health, the Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Public Health, the Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Center for Diseases Control and Prevention of Yunyan District","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyu","family":"Chen","sequence":"additional","affiliation":[{"name":"Clinical Trials Center & Key Laboratory of Clinical Pharmacology and Translational Research, The Affiliated Hospital of Guizhou Medical University","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieyi","family":"He","sequence":"additional","affiliation":[{"name":"Clinical Trials Center & Key Laboratory of Clinical Pharmacology and Translational Research, The Affiliated Hospital of Guizhou Medical University","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaya","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Affiliated Hospital of Guizhou Medical University","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"He","sequence":"additional","affiliation":[{"name":"Clinical Trials Center & Key Laboratory of Clinical Pharmacology and Translational Research, The Affiliated Hospital of Guizhou Medical University","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Hong","sequence":"additional","affiliation":[{"name":"School of Public Health, the Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-0475","article-title":"Association of insulin resistance with cardiovascular disease and all-cause mortality in type 1 diabetes: Systematic review and meta-analysis","volume":"47","author":"Sun","year":"2024","journal-title":"Diabetes Care"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2531","article-title":"Insulin resistance and incident heart failure: A meta-analysis","volume":"24","author":"Erqou","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-020-05163-y","article-title":"Sex-specific associations of insulin resistance with chronic kidney disease and kidney function: A bi-directional mendelian randomisation study","volume":"63","author":"Zhao","year":"2020","journal-title":"Diabetologia"},{"key":"B4","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12933-024-02392-y","article-title":"Diagnostic and prognostic value of triglyceride glucose index: A comprehensive evaluation of meta-analysis","volume":"23","author":"Nayak","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02241-y","article-title":"Triglyceride-glucose index and health outcomes: An umbrella review of systematic reviews with meta-analyses of observational studies","volume":"23","author":"Yin","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: A scientific statement from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: A presidential advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"B8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1101\/2025.04.21.25323810","article-title":"Rising prevalence of cardiovascular-kidney-metabolic syndrome in China, 2010-2019: National cross-sectional surveys","volume":"86","author":"He","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.6892","article-title":"Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 2011-2020","volume":"331","author":"Aggarwal","year":"2024","journal-title":"JAMA J Am Med Assoc"},{"key":"B10","doi-asserted-by":"publisher","first-page":"101474","DOI":"10.1016\/j.lanwpc.2025.101474","article-title":"Long-term trends in the prevalence of cardiovascular-kidney-metabolic syndrome in South Korea, 2011-2021: A representative longitudinal serial study","volume":"55","author":"Yim","year":"2025","journal-title":"Lancet Regional Health Western Pacific"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(24)00685-8","article-title":"Burden of disease scenarios for 204 countries and territories, 2022-2050: A forecasting analysis for the Global Burden of Disease Study 2021","volume":"403","author":"Albakri","year":"2024","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(24)00933-4","article-title":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: A systematic analysis for the Global Burden of Disease Study 2021","volume":"403","author":"Aboagye","year":"2024","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1681\/asn.0000000658","article-title":"Global burden of the key components of cardiovascular-kidney-metabolic syndrome","volume":"36","author":"Xie","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s13098-025-01882-7","article-title":"Association between different dimensions of the C-reactive protein-triglyceride-glucose index and future cardiovascular disease risk in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: A nationwide cohort study","volume":"17","author":"Chen","year":"2025","journal-title":"Diabetol Metab Syndr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12933-025-02662-3","article-title":"Comparison of triglyceride glucose index and modified triglyceride glucose indices in predicting cardiovascular diseases incidence among populations with cardiovascular-kidney-metabolic syndrome stages 0-3: A nationwide prospective cohort study","volume":"24","author":"Hong","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2025.082","article-title":"Association of the triglyceride-glucose index with cardiovascular outcomes across cardiovascular-kidney-metabolic syndrome stages","volume":"40","author":"Kim","year":"2025","journal-title":"Korean J Internal Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"5854","DOI":"10.1038\/s41598-025-87416-7","article-title":"Joint association of TyG index and LDL-C with all-cause and cardiovascular mortality among patients with cardio-renal-metabolic disease","volume":"15","author":"Lai","year":"2025","journal-title":"Sci Rep-UK"},{"key":"B18","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12933-025-02848-9","article-title":"C-reactive protein-triglyceride glucose index in evaluating cardiovascular disease and all-cause mortality incidence among individuals across stages 0-3 of cardiovascular-kidney-metabolic syndrome: A nationwide prospective cohort study","volume":"24","author":"Ou","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s13098-025-01919-x","article-title":"Comparative analysis of 16 baseline obesity and lipid-related indices for cardiovascular disease risk prediction in adults with cardiovascular-kidney-metabolic syndrome stages 0-3: A nationwide prospective cohort study","volume":"17","author":"Pan","year":"2025","journal-title":"Diabetol Metab Syndr"},{"key":"B20","doi-asserted-by":"publisher","first-page":"112327","DOI":"10.1007\/978-1-59745-192-5_12","article-title":"Associations between insulin resistance indices and cardiovascular disease in older adults with cardiovascular-kidney-metabolic syndrome stage 0-3: The GOLD-Health cohort","volume":"226","author":"Wang","year":"2025","journal-title":"Diabetes Res Clin Pr"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2025.06.1036","article-title":"The correlation between triglyceride-glucose index and its associated indices with all-cause and cardiovascular mortality in patients with advanced-stage cardiovascular-kidney-metabolic syndrome","volume":"34","author":"Yan","year":"2025","journal-title":"Heart Lung Circ"},{"key":"B22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12933-025-02642-7","article-title":"Association between triglyceride-glucose related indices and all-cause and cardiovascular mortality among the population with cardiovascular-kidney-metabolic syndrome stage 0-3: A cohort study","volume":"24","author":"Zhang","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-093383","article-title":"Association of the triglyceride-glucose index with all-cause and cardiovascular mortality among individuals with cardiovascular-kidney-metabolic syndrome: A population-based cohort study using data from the US National Health and Nutrition Examination Survey, 1999-2018","volume":"15","author":"Zhao","year":"2025","journal-title":"BMJ Open"},{"key":"B24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12933-025-02842-1","article-title":"Triglyceride-glucose-related indices and risk of cardiovascular disease and mortality in individuals with cardiovascular-kidney-metabolic (CKM) syndrome stages 0-3: A prospective cohort study of 282,920 participants in the UK Biobank","volume":"24","author":"Liu","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"495","DOI":"10.12182\/20250360503","article-title":"Association between surrogate markers of insulin resistance and incident cardiovascular disease in a population with stages 0-3 cardiovascular-kidney-metabolic syndrome: A prospective cohort study","volume":"56","author":"Zhao","year":"2025","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.31222\/osf.io\/v7gm2","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ-Brit Med J"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA J Am Med Assoc"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/aje\/kwr265","article-title":"Meta-analysis for linear and nonlinear dose-response relations: Examples, an evaluation of approximations, and software","volume":"175","author":"Orsini","year":"2012","journal-title":"Am J Epidemiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clin Trials"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwj141","article-title":"Combining risk estimates from observational studies with different exposure cutpoints: A meta-analysis on body mass index and diabetes type 2","volume":"163","author":"Hartemink","year":"2006","journal-title":"Am J Epidemiol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwn005","article-title":"How much of the data published in observational studies of the association between diet and prostate or bladder cancer is usable for meta-analysis","volume":"167","author":"Bekkering","year":"2008","journal-title":"Am J Epidemiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199507000-00005","article-title":"Dose-response and trend analysis in epidemiology: Alternatives to categorical analysis","volume":"6","author":"Greenland","year":"1995","journal-title":"Epidemiology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3841","article-title":"Dose-response analyses using restricted cubic spline functions in public health research","volume":"29","author":"Desquilbet","year":"2010","journal-title":"Stat Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0258(20000730)19:14<1831::aid-sim502>3.0.co;2-1","article-title":"A strategy for modelling the effect of a continuous covariate in medicine and epidemiology","volume":"19","author":"Royston","year":"2000","journal-title":"Stat Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ-Brit Med J"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.116.08994","article-title":"Dose-response association between physical activity and incident hypertension: A systematic review and meta-analysis of cohort studies","volume":"69","author":"Liu","year":"2017","journal-title":"Hypertension"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1177\/2047487320914756","article-title":"HDL-C is associated with mortality from all causes, cardiovascular disease and cancer in a J-shaped dose-response fashion: A pooled analysis of 37 prospective cohort studies","volume":"27","author":"Zhong","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.60026","article-title":"Digital screen time and myopia: A systematic review and dose-response meta-analysis","volume":"8","author":"Ha","year":"2025","journal-title":"JAMA Netw Open"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-026-03077-4","article-title":"Relationship between nine triglyceride-glucose-related indices and cardiometabolic multimorbidity incidence in patients with cardiovascular-kidney-metabolic syndrome stage 0-3: A nationwide prospective cohort study","volume":"25","author":"Jin","year":"2026","journal-title":"Cardiovasc Diabetol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12933-025-03057-0","article-title":"Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome: Evidence from international multi-cohort studies","volume":"25","author":"Li","year":"2026","journal-title":"Cardiovasc Diabetol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12933-026-03076-5","article-title":"Association between the triglyceride-glucose-frailty index and all-cause and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome: The mediating role of the poverty-income ratio","volume":"25","author":"Wang","year":"2026","journal-title":"Cardiovasc Diabetol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"E214","DOI":"10.1097\/00001573-199010000-00003","article-title":"Glucose clamp technique: A method for quantifying insulin secretion and resistance","volume":"237","author":"DeFronzo","year":"1979","journal-title":"Am J Physiol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","article-title":"Triglyceride-glucose index as a marker in cardiovascular diseases: Landscape and limitations","volume":"21","author":"Tao","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2462466","article-title":"Recent advances in immunotherapy targeting CETP proteins for atherosclerosis prevention","volume":"21","author":"Hu","year":"2025","journal-title":"Hum Vacc Immunother"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02576-0","article-title":"Association of different insulin resistance surrogates with all-cause and cardiovascular mortality among the population with cardiometabolic multimorbidity","volume":"24","author":"Zhang","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12933-024-02306-y","article-title":"Which surrogate insulin resistance indices best predict coronary artery disease? A machine learning approach","volume":"23","author":"Mirjalili","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10010092","article-title":"Triglyceride glucose-waist circumference better predicts coronary calcium progression compared with other indices of insulin resistance: A longitudinal observational study","volume":"10","author":"Cho","year":"2020","journal-title":"J Clin Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109042","article-title":"The triglyceride-glucose index is a more powerful surrogate marker for predicting the prevalence and incidence of type 2 diabetes mellitus than the homeostatic model assessment of insulin resistance","volume":"180","author":"Park","year":"2021","journal-title":"Diabetes Res Clin Pr"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154766","article-title":"Insulin resistance, cardiovascular stiffening and cardiovascular disease","volume":"119","author":"Hill","year":"2021","journal-title":"Metab Clin Exp"},{"key":"B52","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrcardio.2009.55","article-title":"Obesity, inflammation, and atherosclerosis","volume":"6","author":"Rocha","year":"2009","journal-title":"Nat Rev Cardiol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-018-0044-8","article-title":"Metabolites as regulators of insulin sensitivity and metabolism","volume":"19","author":"Yang","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.116.306206","article-title":"Insulin signaling and heart failure","volume":"118","author":"Riehle","year":"2016","journal-title":"Circ Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2015.216","article-title":"Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy","volume":"12","author":"Jia","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1172\/jci77812","article-title":"The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux","volume":"126","author":"Samuel","year":"2016","journal-title":"J Clin Invest"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12562","article-title":"Calcium signalling and ER stress in insulin resistance and atherosclerosis","volume":"280","author":"Ozcan","year":"2016","journal-title":"J Intern Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyz068","article-title":"The culprit is the carrier, not the loads: cholesterol, triglycerides and apolipoprotein B in atherosclerosis and coronary heart disease","volume":"48","author":"Ala-Korpela","year":"2019","journal-title":"Int J Epidemiol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrtlng.2024.06.006","article-title":"Association between oxidative balance score and heart failure in the older adults: Results from the NHANES 2005-2018","volume":"68","author":"Jia","year":"2024","journal-title":"Heart Lung"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2026.108540","article-title":"Association between cumulative changes of the triglyceride glucose index and incidence of Cardio-cerebral vascular diseases in a population with cardiovascular-kidney-metabolic syndrome stage 0-3: a nationwide prospective cohort study","volume":"35","author":"Hou","year":"2026","journal-title":"J Stroke Cerebrovascular Dis"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02457-y","article-title":"Trajectories of triglyceride-glucose index changes and their association with all-cause and cardiovascular mortality: a competing risk analysis","volume":"23","author":"Lee","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.918359","article-title":"Comparison of three non-insulin-based insulin resistance indexes in predicting the presence and severity of coronary artery disease","volume":"9","author":"Wu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12101698","article-title":"Association between different insulin resistance indices and heart failure in US adults with diabetes mellitus","volume":"29","author":"Chen","year":"2024","journal-title":"Ann Noninvas Electro"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.2105\/ajph.2014.302330","article-title":"Diabetes and hypertension prevalence in homeless adults in the United States: a systematic review and meta-analysis","volume":"105","author":"Bernstein","year":"2015","journal-title":"Am J Public Health"},{"key":"B65","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.diabres.2014.01.002","article-title":"Prevalence, trends and risk factors for the diabetes epidemic in China: a systematic review and meta-analysis","volume":"104","author":"Zuo","year":"2014","journal-title":"Diabetes Res Clin Pr"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2014.08.019","article-title":"Trends in the prevalence of type 2 diabetes mellitus and obesity in the Arabian Gulf States: systematic review and meta-analysis","volume":"106","author":"Alharbi","year":"2014","journal-title":"Diabetes Res Clin Pr"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1959631\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:37:11Z","timestamp":1790224631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1959631\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":66,"alternative-id":["10.3389\/fendo.2026.1959631"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1959631","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"article-number":"1959631"}}